维普中文期刊产品整合服务
45篇 您的检索式:作者名="LARSEN ML"
    题名 作者 年代 出处 被引量
1Techniques and materials for skin closure in caesarean section 显示文摘Mackeen AD Berghella V Larsen ML 2012Cochrane Database Syst Rev2012,11,00:1
2manufacturing and standardizing allergen extract in Europe显示文摘Larsen Houghton CG Vega ML etal 2008Clin Allergy immunol2008,21,:1
3Risk of non-small cell lung cancer and the cytochrome P-4501A1 Ile462 Val ploymor-phism显示文摘Larsen JE Colosimo ML Yang IA 2005Cancer Causes Control2005,16,5:1
4Risk of nonsmall cell lung cancer and the cytochroe P-4501A1 Ile 462 Val Polymorphism显示文摘Larsen JE Colosimo ML Yang I A 2005Cancer Causes Control2005,16,5:1
5Risk of non-small celllung cancer and the cytochrome P4501A1 Ile462Val polymorphism显示文摘Larsen JE Colosimo ML Yang IA 2005Cancer Causes Control2005,16,5:1
6Role of vasavasorum innourishment of the aortic wall显示文摘Heistad DD Marcus ML Larsen GE 1981Heart and Circulatory Physiology1981,240,5:1
7Fluoride is unable to reduce dental erosion from soft drinks显示文摘Larsen ML Richards A 2002Caries Res2002,36,1:1
8Retinal microvascular signs,cognitive function,and dementia in older persons:The Cardiovascular Health Study显示文摘Baker ML Larsen EK Kuller LH 2007Stroke2007,38,7:1
9Extreme levels of hyperlipidaemia as a cause of acute pancreatitis显示文摘Johansen ME Mattsson N Larsen ML 2010Ugeskr Laeger2010,172,40:1
10Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomemlopathy显示文摘Larsen CP Beggs ML Saeed M 2013J Am Soc Nephrol2013,24,5:1
11No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes 显示文摘Damgaard D Jensen JM Larsen ML 2004Atherosclerosis2004,177,2:1
12Genetic association study of CYP1A1 polymerphisms identifies risk haplotypes in nonsmall cell lung cancer显示文摘Wright CM Larsen JE Colosimo ML 2010Eur Respir J2010,35,1:1
13How can we identify low-and high-risk patients among unselected patients with possible acute coronary syndrome显示文摘Nielsen KM Faergeman O Larsen ML 2007Am Emerg Med2007,25,1:1
14Comparison of atorvastatin 80 mg/day versus simvastatin 20 Lo 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering trial) 显示文摘Pedersen TR Cater NB Faergeman O Kastelein JJ Olsson AG Tikkanen M J Holme I Larsen ML Lindahl C Szarek M 2010Am J Cardiol2010,106,3:1
15The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population显示文摘Damgaard D Larsen ML Nissen PH 2005Atherosclerosis2005,180,1:1
16Setting analytical goals for random analytical error in specific clinical monitoring situations 显示文摘FRASER CG HYLTOFT PP LARSEN ML 1990Clin Chem1990,36,9:1
17River discharge and local-scale physical habitat influence macroinvertebrate LIFE scores 显示文摘Dunbar MJ Pedersen ML Cadman D Extence C Waddingham J Chadd R Larsen SE 2010Freshwater Biol2010,55,1:1
18Membranous nephropa- thy and nonsteroidal anti-inflammatory agents显示文摘Nawaz FA Larsen CP Troxell ML 2013Am J Kid- ney Dis2013,62,5:1
19How can we identify low-and high-risk patients among unselected patients with possible acute coronary syndrome显示文摘 Faergeman O Larsen ML 2007Am Emerg Med2007,25,1:1
20Glucose-dependent regulation of osteoclast H+-ATPase expression:potential role of p38 MAPKinase显示文摘Larsen KI Falany ML Ponomareva LV 2002J Cell Biochem2002,87,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费